ASCELLA BIOSYSTEMS, INC. — Form D

ASCELLA BIOSYSTEMS, INC. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-12-28. The offering totals $6.3M, of which $6.3M was reported sold. Industry: Other Health Care.

Offering

• Filed: 2023-12-28
• Form: D
• Accession: 0002006111-23-000001
• Industry: Other Health Care
• Exemptions: 06b
• Total offering: $6.3M
• Amount sold: $6.3M
• Investors: 11
• Date of first sale: 2023-12-18
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-501010

Issuer

• Name: ASCELLA BIOSYSTEMS, INC.
• CIK: 0002006111
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2020
• Address: 150 HOOPER STREET, SUITE 212, SAN FRANCISCO, CA, 94107
• Phone: 650-832-1142

Officers, directors & promoters (6)

More

• CIK 2006111 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search